LRMR - Wall Street Estimates - Larimar Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.85

-5.94 %

$ 182 M

Market Cap

-2.48

P/E

Price Target Average

566.67%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

31.54%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Larimar Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for LRMR of $19 , with forecasts ranging from a low of $14 to a high of $25 .

LRMR Lowest Price Target Wall Street Target

14 USD 391.23%

LRMR Average Price Target Wall Street Target

19 USD 566.67%

LRMR Highest Price Target Wall Street Target

25 USD 777.19%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free